14 September 2018 - The heads of the Netherland’s Medicines Evaluation Board and Swissmedic have signed a memorandum of understanding allowing for greater collaboration between the two regulators.

According to a joint release by both regulators, the agreement “provides a formal basis for stepping up collaboration on bilateral initiatives and the exchange of data” and adds to their ongoing participation in international efforts such as the International Coalition of Medicines Regulatory Authorities (ICMRA) and International Council for Harmonisation.

“Given the constantly evolving regulatory environment and the ever more global and complex nature of therapeutic product development and production, international collaboration is an important factor in meeting the growing challenges,” the regulators write.

Read Regulatory Affairs Professional Society article